ライフサイエンスコーパス: SPECT

1 SPECT and CT images were acquired 24 h after injection o

2 SPECT cameras with solid-state detectors can obtain dyna

3 SPECT HMR calculated on the basis of UM, LM, and CL back

4 SPECT HMR was quantified using a new method that incorpo

5 SPECT HMR with UM resulted in highest correlation (R = 0

6 SPECT imaging and bioluminescence imaging were performed

7 SPECT imaging of (125)I-ACKR3-mAb showed the versatility

8 SPECT imaging of (213)Bi is challenging, because most em

9 SPECT imaging revealed that (111)In-PEG-GIRLRG specifica

10 SPECT scans were acquired over 90 min in 16 healthy cont

11 SPECT/CT identified hotspots in 4 patients at sites wher

12 SPECT/CT imaging of MPO activity showed marked MPO-senso

13 SPECT/CT imaging with (99m)Tc-S-HYNIC-28H1 specifically

14 SPECT/CT scans were acquired at 1, 24, and 48 h after in

15 SPECT/CT was used to measure the in vivo uptake of (99m)

16 SPECT/MRI of the mouse model found better tumor visualiz

17 SPECT/muCT imaging with (99m)Tc-NbV4m119 allows specific

18 led patients underwent bone SPECT/CT, with 1 SPECT acquisition followed by 2 randomized CT acquisitio

19 In patients with high CACS (>/=400), SPECT had lower sensitivity than CCTA (50% vs 100%) and

20 In patients with low CACS (<400), SPECT had a lower sensitivity than CCTA (60% versus 80%)

21 of ezetimibe monitored by (99m)Tc-cAbVCAM1-5 SPECT showed a 49% reduction in aortic tracer uptake (pe

22 the application of both (125)I-iodo-DPA-713 SPECT/CT and DPA-713-IRDye800CW near-infrared fluorescen

23 im idin-3-yl)acetamide ((125)I-iodo-DPA-713) SPECT/CT or (18)F-FDG PET/CT.

24 al segment with inducible ischemia in Tc-99m SPECT who underwent bone marrow biopsy and were allocate

25 al segment with inducible ischemia in Tc-99m SPECT who underwent bone marrow biopsy and were allocate

26 nexpected potential of (99m)Tc-PSMA-I&S as a SPECT imaging agent.

27 We used (123)I-iodobenzovesamicol, a SPECT radiotracer of the vesicular acetylcholine transpo

28 ologically active compounds such as PIMBA, a SPECT imaging agent of breast cancer, and (-)-IBZM, a do

29 c rest-stress measurements were made using a SPECT camera.

30 cancer xenograft mouse model, we validated a SPECT/CT-based theranostic PRIT regimen that led to 100%

31 ted, filled with (177)Lu, and scanned with a SPECT/CT system.

32 The frequency of abnormal SPECT increased with higher CAC scores, from 12% in pati

33 In patients with abnormal SPECT MPI, the extent of abnormality is independently as

34 In addition, SPECT/CT imaging was potentially more sensitive than the

35 In addition, SPECT/muCT imaging was used to investigate arthritis dev

36 At 3, 6, 12, and 24 h after administration, SPECT/CT images were acquired or mice were sacrificed fo

37 After SPECT acquisition, the muscles containing the transplant

38 s to exit after PET/CT imaging or just after SPECT radiopharmaceutical injection appears to be safe f

39 2.77 [95% CI, 1.85 to 4.16]; P < 0.001) and SPECT (hazard ratio, 1.62 [CI, 1.11 to 2.38; P = 0.014)

40 jective: To establish the ability of CMR and SPECT to predict major adverse cardiovascular events (MA

41 n a high-volume institution for both CMR and SPECT).

42 The CT and SPECT components of diagnostic SPECT/CT strongly complem

43 The development of PET/CT and SPECT/CT imaging systems, which combine anatomic and fun

44 Furthermore, PET/CT and SPECT/MRI were performed.

45 lanar near-infrared fluorescence imaging and SPECT, respectively, was evaluated in implanted and gene

46 We use MRI and SPECT data of 538 subjects from the PPMI database, and o

47 ging of PSMA-positive PC by means of PET and SPECT as well as a dramatic response of metastatic castr

48 ninvasive imaging techniques such as PET and SPECT have been explored for biomarker development, with

49 e blood concentration of most common PET and SPECT radiotracers with high temporal resolution in smal

50 ibrated solutions of the most common PET and SPECT radiotracers.

51 Although PET and SPECT remain clinical mainstays, optical readouts of ion

52 Imaging agents for PET and SPECT that target NMDARs in a subtype-selective fashion

53 Planar and SPECT images of the abdomen were acquired at 30 min and

54 Serial planar and SPECT/CT images were used to determine time-activity cur

55 Discrepancies between the gamma-probe and SPECT/CT may be due to missed SNs during surgery, but wi

56 CAD was 39% (36 of 92) according to QCA and SPECT and 64% (59 of 92) according to QCA alone.

57 When compared with QCA and SPECT, per-patient diagnostic accuracy of perfusion CT a

58 CAC score and SPECT are independent predictors of MACE in patients sus

59 s could be visualized with both small-animal SPECT and fluorescence imaging from the first week of tu

60 CP-1 or control peptide using a small-animal SPECT imager: Group I (n=5) received no blockade; Group

61 Small-animal SPECT images and optical images were acquired, and image

62 in a rat model with a dedicated small-animal SPECT scanner by targeting the glucagonlike peptide-1 re

63 rformed in C57BL/6 mice by both small-animal SPECT/CT and ex vivo biodistribution studies.

64 On in vivo small-animal SPECT/CT and ex vivo planar images, the MMP signal was s

65 ctivation was imaged by in vivo small-animal SPECT/CT followed by ex vivo planar imaging.

66 In vivo (99m)Tc-RYM1 small-animal SPECT/CT images showed higher uptake of the tracer in AA

67 Biodistribution and small-animal SPECT/CT imaging (18.5 +/- 2.6 MBq) with 25 mug of (111)

68 Biodistribution and small-animal SPECT/CT imaging studies were performed to evaluate tumo

69 ng with (64)Cu-cetuximab and of small-animal SPECT/CT imaging with (177)Lu-cetuximab, including blood

70 /-) (n = 16) mice were used for small-animal SPECT/CT imaging.

71 Small-animal SPECT/CT-based MMP-targeted imaging of the lungs is feas

72 significant correlation between small-animal SPECT/CT-derived MMP signal and CD68 expression in the l

73 ould clearly be visualized with small-animal SPECT/CT.

74 In Mayo Clinic, Rochester, annual SPECT utilization in patients with previous CAD increase

75 vasive molecular imaging techniques, such as SPECT and PET, provide information on the whole-body dis

76 The studies assessing SPECT use in temporal lobe epilepsy did not reveal a cor

77 for activity determination of (177)Lu-based SPECT/CT imaging reconstructed with 2 commercially avail

78 rthermore, the system detected (99m)Tc-based SPECT tracers with an efficiency of 4%, an outcome not p

79 astatic PCa via sequential planar whole-body SPECT imaging at 1, 3, 5, and 21 h after injection.

80 Whole-body SPECT/CT images allowed clear tumor visualization with l

81 Conclusion:(18)F-NaF PET/CT and whole-body SPECT/CT resulted in a significant reduction of equivoca

82 pBS and whole-body SPECT/CT were performed followed by (18)F-NaF PET/CT wit

83 The use of 70% ASiR blending in bone SPECT/CT can reduce the CT radiation dose by 60%, with n

84 of this study was to compare a routine bone SPECT/CT protocol using CT reconstructed with filtered b

85 tive study, enrolled patients underwent bone SPECT/CT, with 1 SPECT acquisition followed by 2 randomi

86 After multivariate analysis, both SPECT and CAC score were independent predictors of MACE

87 o (simultaneous) preclinical imaging of both SPECT and PET isotopes over a wide photon energy range o

88 t of the abdominal activity concentration by SPECT/CT 4 d after the administration of (177)Lu-DOTATAT

89 as radiolabeled with (125)I and evaluated by SPECT imaging and ex vivo biodistribution studies.

90 erebral apoptosis, and CBF were evaluated by SPECT/CT up to 14 d after MCAO.

91 as absolute change in myocardial ischemia by SPECT.

92 myocardial blood flow (MBF) measurements by SPECT.

93 t that among patients with a history of CAD, SPECT was being increasingly utilized in patients with m

94 ages were acquired using a dedicated cardiac SPECT system with 19 pinhole collimators interfaced with

95 o establish the diagnostic accuracy of CCTA, SPECT, and PET and explore the incremental value of hybr

96 (123) I-FP-CIT SPECT and (123) I-MIBG myocardial scintigraphy have simi

97 All patients underwent (123) I-FP-CIT SPECT and (123) I-MIBG myocardial scintigraphy within a

98 e differences in extrastriatal (123)I-FP-CIT SPECT binding to SERT between MSA, PSP, and PD.

99 tigraphy, and 90% and 76% for (123) I-FP-CIT SPECT.

100 eta-(4-iodophenyl)nortropane ((123)I-FP-CIT) SPECT can visualize and quantify striatal dopamine trans

101 probes underlines the potential of combining SPECT imaging with fluorescence guidance and shows the p

102 ar images were acquired using a conventional SPECT camera equipped with parallel hole collimators, an

103 , with no sacrifice in attenuation-corrected SPECT and CT image quality, compared with the convention

104 image quality of both attenuation-corrected SPECT and CT images was visually (5-point Likert scale,

105 no difference between attenuation-corrected SPECT images issued from FBP CT or ASiR CT for both inte

106 vely, for attenuation- and scatter-corrected SPECT versus point-spread function (PSF) model-based and

107 by visual evaluation, with the corresponding SPECT/CT Bremsstrahlung images by 2 experienced radiolog

108 ography (QCA) and single-photon emission CT (SPECT) or QCA alone.

109 es are warranted to potentiate (99m)Tc-CXCL8 SPECT as a biomarker to scale up or step down treatment

110 we investigate the accuracy of (99m)Tc-CXCL8 SPECT to detect and localize disease activity in a prosp

111 prognostic value of MPI performed with a CZT SPECT camera in a large cohort of patients suspected of

112 r findings show that MPI acquired with a CZT SPECT camera provides excellent prognostic information,

113 timation of absolute MBF index values by CZT SPECT MPI with (99m)Tc-tetrofosmin is technically feasib

114 ion imaging (MPI) by (99m)Tc-tetrofosmin CZT SPECT and (13)N-ammonia PET, and MFR was calculated as a

115 ory of coronary artery disease underwent CZT SPECT MPI.

116 (MPI) with the cadmium-zinc-telluride (CZT) SPECT camera is not well established.

117 as (Discovery NM 530c) than for the other (D-SPECT) or the conventional camera (respectively, 40.5 +/

118 her for the Discovery NM 530c than for the D-SPECT or the conventional camera, leading to decreased L

119 ynucleinopathy in patients with abnormal DAT-SPECT than with normal DAT-SPECT (20% vs 6% at 3 years,

120 After DAT-SPECT, patients were followed up during 5.7 +/- 2.2 (ran

121 -confirmed IRBD underwent (123) I-FP-CIT DAT-SPECT.

122 ing serial dopamine transporter imaging (DAT-SPECT) and ICD assessment (Questionnaire for Impulsive-C

123 INTERPRETATION: DAT-SPECT identifies IRBD patients at short-term risk for sy

124 with abnormal DAT-SPECT than with normal DAT-SPECT (20% vs 6% at 3 years, 33% vs 18% at 5 years; log

125 tched controls without RBD who underwent DAT-SPECT.

126 At 5-year follow-up, DAT-SPECT had 75% sensitivity, 51% specificity, 44% positive

127 risk SPECT tests increased despite decreased SPECT utilization between 2003 and 2012.

128 n, allowing use of the new cardiac-dedicated SPECT camera for (123)I-mIBG imaging.

129 The results of this study demonstrate SPECT/CT as a novel tool for 4D (i.e., transient three-d

130 Nuclide-dependent SPECT/CT calibration factors were determined to assess t

131 previous planar HMR threshold and determined SPECT LLN HMR for SPECT.

132 r administration of contrast; and diagnostic SPECT/CT at 24 h.

133 server agreement was moderate for diagnostic SPECT/CT (kappa = 0.44), diagnostic CT (kappa = 0.43), l

134 ; and 77.8%, 84.0%, and 88.9% for diagnostic SPECT/CT.

135 The CT and SPECT components of diagnostic SPECT/CT strongly complemented each other, as 34 of 82 l

136 e SPECT/CT was also detectable on diagnostic SPECT/CT.

137 management was influenced by the diagnostic SPECT/CT interpretation in 8 of 31 patients (25.8%).

138 Technetium 99m hydroxymethane diphosphonate SPECT/CT bone tracer uptake was volumetrically quantifie

139 planar imaging at 4, 24, and 48 h; low-dose SPECT/CT at 24 and 48 h; diagnostic CT at 24 h using a t

140 PECT/CT at 48 h (kappa = 0.61), and low-dose SPECT/CT at 24 h (kappa = 0.55).

141 3 were 51.9%, 49.4%, and 71.6% for low-dose SPECT/CT at 24 h; 51.9%, 55.6%, and 67.9% for low-dose S

142 .44), diagnostic CT (kappa = 0.43), low-dose SPECT/CT at 48 h (kappa = 0.61), and low-dose SPECT/CT a

143 t 24 h; 51.9%, 55.6%, and 67.9% for low-dose SPECT/CT at 48 h; 63.0%, 70.4%, and 85.2% for diagnostic

144 ion detectable on planar imaging or low-dose SPECT/CT was also detectable on diagnostic SPECT/CT.

145 response was evaluated by (99m)Tc-duramycin SPECT 24 h after the last dose of therapy.

146 evaluation was assessed by (99m)Tc-duramycin SPECT and (18)F-FDG PET imaging in treatment-sensitive C

147 ve imaging approach, we investigated dynamic SPECT imaging with kinetic modeling in healthy humans to

148 hybrid cameras that combine MRI with either SPECT or PET has stimulated growing interest in developi

149 AP, in amyloid-laden mice, using dual-energy SPECT imaging and tissue biodistribution measurements.

150 Bq) and rest (5 min; 1,024 +/- 153 MBq) fast SPECT MPI attenuation corrected (AC) by CT and same-day

151 Bq) and rest (5 min; 1,024 +/- 153 MBq) fast SPECT MPI attenuation corrected (AC) by CT and same-day

152 gents targeting PSMA have been developed for SPECT and PET platforms.

153 (123)I-CLINDE is a radiotracer developed for SPECT and targets the 18-kDa translocator protein (TSPO)

154 R threshold and determined SPECT LLN HMR for SPECT.

155 patient had been referred for PET/CT or for SPECT/CT.

156 for building multimodality radiotracers for SPECT/MRI and PET/MRI.

157 tory of coronary artery disease referred for SPECT and CAC scoring were included.

158 ns was significantly higher for pBS than for SPECT/CT and PET/CT (18 vs. 5 and 6, respectively; P = 0

159 uring segmentation of the left ventricle for SPECT myocardial perfusion imaging (MPI) quantification

160 activity concentrations were calculated from SPECT acquisitions at multiple time points, and tumor ma

161 diation absorbed doses to tumor derived from SPECT/CT (102 Gy) and from biodistribution (110 Gy) agre

162 Planar HMR can be estimated from SPECT HMR via a simple linear regression equation, allow

163 itative methodologies for assessing HMR from SPECT images using a dedicated cardiac multipinhole SPEC

164 the calculation of absorbed dose to RM from SPECT/CT images.

165 istology, retrospectively reviewed all fused SPECT/MR images and scored morphologic SLN parameters on

166 Global SPECT MFR with +MC and +BB had an area under the receive

167 mproved the accuracy and precision of global SPECT MBF compared with PET MBF, resulting in an average

168 planar bone scintigraphy (pBS), (99m)Tc-HDP SPECT/CT, (18)F-NaF PET/CT, and (18)F-NaF PET/MRI for th

169 e (15)O-water PET after normal (99m)Tc-HMPAO SPECT results with respect to CVRC.

170 th stenoocclusion and negative (99m)Tc-HMPAO SPECT.

171 T and the negative findings in (99m)Tc-HMPAO SPECT.

172 Hybrid SPECT and CT images were used to estimate the activity c

173 d with parallel hole collimators, and hybrid SPECT/CT images were acquired using a dedicated cardiac

174 c accuracy was not enhanced by either hybrid SPECT and CCTA (76%; 95% CI, 70%-82%; P = .75) or by PET

175 n alternative, especially when hybrid (123)I SPECT/CT is not available.

176 ned on the basis of (124)I PET/CT and (131)I SPECT/CT follow-up images.

177 ity between (124)I PSF TOF PET/CT and (131)I SPECT/CT for small spheres (</=10 mm), since the reporte

178 ults as compared with posttherapeutic (131)I SPECT/CT may be ascribed to differences in detectability

179 Recent advances in SPECT technology including cadmium-zinc-telluride (CZT)

180 much higher energy (440 keV) than common in SPECT.

181 localization, decreasing user dependence in SPECT MPI quantification.

182 localization, decreasing user dependence in SPECT MPI quantification.

183 nderwent a dynamic (123)I-iodobenzovesamicol SPECT scan and an MRI scan.

184 Visual interpretation of (123)I-ioflupane SPECT images has high diagnostic accuracy for differenti

185 ce in the interpretation of (123)I-ioflupane SPECT scans to have diagnostic accuracy equivalent to th

186 ent CCTA, technetium 99m/tetrofosmin-labeled SPECT, and [15O]H2O PET with examination of all coronary

187 Time-lapse SPECT imaging results illustrated both local and global

188 d determined the lower limit of normal (LLN) SPECT-derived HMR and the correlation to planar-derived

189 C, predictive dosimetry based on (99m)Tc-MAA SPECT/CT provided good estimates of absorbed doses calcu

190 atment (99m)Tc-macroaggregated albumin (MAA) SPECT/CT.

191 solute quantification of dynamic (123)I-mIBG SPECT images.

192 ECT/CT studies and 186 MBq in 10 (123)I-MIBG SPECT/CT studies.

193 123)I-meta-iodobenzylguanidine ((123)I-mIBG) SPECT/CT after an overnight fast and 2 h of cold exposur

194 ion/metabolism was evaluated by (99m)Tc-MIBI SPECT /(18)F-FDG PET imaging.

195 lve healthy humans underwent 5 serial 15-min SPECT scans at 0, 15, 90, 120, and 180 min after bolus i

196 List-mode SPECT data were reconstructed with CT-based attenuation

197 matostatin receptor scintigraphy on a modern SPECT/CT device were enrolled in this study.

198 tomography, hybrid methods (PET/CT, PET/MRI, SPECT/CT) and ultrasound.

199 mages using a dedicated cardiac multipinhole SPECT/CT system and determined the lower limit of normal

200 Nano-SPECT/CT imaging of the mice was performed 48 and 72 h a

201 cedure with preoperative (99m)Tc-nanocolloid SPECT/CT-based SLN mapping.

202 or less and relative diagnostic accuracy of SPECT, PET, and CCTA in detecting hemodynamically signif

203 canning can be improved with the addition of SPECT/CT.

204 chnique for geometry-specific calibration of SPECT/CT systems.

205 oes not support the prognostic importance of SPECT in patients undergoing temporal lobe surgery.

206 Additionally, the influence of SPECT/CT on patient management was evaluated.

207 que for a geometry-specific investigation of SPECT/CT reconstruction parameters and PVC methods.

208 The LLN of SPECT HMR with UM and that of planar HMR was calculated

209 ignificant differences in the sensitivity of SPECT/CT, PET/CT, and PET/MRI compared with pBS, but a l

210 The trends of SPECT studies among patients with known CAD have not bee

211 indications, diagnostic accuracy, the use of SPECT/CT and CT angiography to evaluate gastrointestinal

212 Annual utilization of SPECT in these patients increased from an average of 495

213 The normal values of SPECT-derived HMR and planar-derived HMR were correlated

214 On SPECT, (166)Ho could be quantified with high accuracy an

215 , 7.7; P<0.001 and large perfusion defect on SPECT: hazard ratio, 3.7; P<0.001).

216 e, and quantification of the microspheres on SPECT and MRI.

217 ng the department after undergoing PET/CT or SPECT/CT in our centers.

218 uding resection of SNs related to the ovary, SPECT/CT was performed within 24 h.

219 analysis were 21%, 15%, 9%, and 7% for pBS, SPECT/CT, PET/CT, and PET/MRI, respectively.

220 , 37.9% to 52.9%), and (111)In-pentetreotide SPECT/CT detected 30.9% of lesions (95% CI, 25.0% to 37.

221 vity was 170 MBq in 12 (111)In-pentetreotide SPECT/CT studies and 186 MBq in 10 (123)I-MIBG SPECT/CT

222 zylguanidine (MIBG) and (111)In-pentetrotide SPECT have been used for functional imaging of neuroendo

223 ated an in vivo BC mouse model and performed SPECT/MRI and biodistribution studies.

224 rd clinical software (quantitative perfusion SPECT) by 2 experts, adjusting the VP if needed.

225 ease and normal findings on stress perfusion SPECT were retrospectively analyzed to provide the refer

226 PET, SPECT, simultaneous EEG and functional MRI, and electric

227 ty, covering recent advances in the MR, PET, SPECT, ultrasound, and optical imaging of ovarian cancer

228 Biodistribution, pharmacokinetics, SPECT/CT, and dosimetry studies were performed to assess

229 Post-SPECT biodistribution data also validated the SPECT imag

230 Post-SPECT biodistribution studies were performed 96 h after

231 urgery with their detection on postoperative SPECT/CT.

232 Preoperative SPECT/CT showed a high (99m)Tc-PSMA-I&S uptake in all su

233 Additionally, preoperative SPECT/CT (12 h after injection) and (99m)Tc-PSMA-I&S-sup

234 After the phantoms had been printed, SPECT/CT acquisitions of 3 radionuclides ((99m)Tc, (177)

235 To assess its biodistribution properties, SPECT and CT scans of HT29-xenografted nude mice injecte

236 al (3D) printing techniques for quantitative SPECT/CT imaging, a set of kidney dosimetry phantoms and

237 e radioisotope have in most centers replaced SPECT-based tracers as the gold standard.

238 ng is a complementary argument for replacing SPECT by PET somatostatin-receptor imaging.

239 High-risk SPECT tests declined, whereas low-risk tests increased m

240 High-risk SPECT tests significantly decreased, and the percentage

241 ly decreased, and the percentage of low-risk SPECT tests increased despite decreased SPECT utilizatio

242 nventional tracer [(123)I]iodide (sequential SPECT/CT).

243 y selected mice undergoing treatment, serial SPECT/CT imaging was used to monitor treatment response

244 P = 0.86) were comparable with CTA versus SO SPECT, respectively.

245 astases according to the reference standard, SPECT/CT, (18)F-NaF PET/CT, and PET/MRI detected additio

246 Solid-state SPECT provides global MBF and MFR measurements that diff

247 Stress SPECT when optimized with SO imaging is similar to CTA i

248 c nuclear cardiology database for all stress SPECT tests performed between January 1991 and December

249 In this study, SPECT measurements of MBF made using (99m)Tc-tetrofosmin

250 e developed an antibody-based PD-L1-targeted SPECT agent-(111)In-diethylenetriaminepentaacetic acid (

251 arterial input function using (99m)TcO4 (-) (SPECT).

252 23)I-mIBG on a hybrid cadmium zinc telluride SPECT/CT system.

253 as not seen macroscopically, indicating that SPECT/CT imaging might be more sensitive than the macros

254 This study showed that SPECT/CT with (99m)Tc-S-HYNIC-28H1 could be used to noni

255 Our results suggest that SPECT biomarkers have the potential to predict radiation

256 To perform voxel dosimetry, the SPECT/CT data and an in-house-developed MATLAB program w

257 atures with objects as small as 2 mm for the SPECT and 0.2 mm for the CT.

258 When fused datasets of the SPECT and MR images were created, SLNs could be identifi

259 etected on only the CT component or only the SPECT component.

260 maging allows better quantification than the SPECT technique.

261 hat has been shown to be far superior to the SPECT tracer (111)In-diethylenetriaminepentaacetic acid-

262 PECT biodistribution data also validated the SPECT imaging results.

263 (82)Rb or (13)N-ammonia within 1 mo of their SPECT study.

264 upport performing a CAC score in addition to SPECT in symptomatic patients to better define the risk

265 upports the role of CMR as an alternative to SPECT for the diagnosis and management of patients with

266 single-photon emission computed tomography (SPECT) and positron emission tomography (PET).

267 single photon emission computed tomography (SPECT) and X-ray computed tomography (CT) for investigat

268 single-photon emission computed tomography (SPECT) in patients suspected for coronary artery disease

269 single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies among patien

270 single-photon emission computed tomography (SPECT) revealed significantly higher levels of each mole

271 single-photon emission computed tomography (SPECT) scanning.

272 single photon emission computed tomography (SPECT) with technetium 99m ((99m)Tc) tropane dopamine tr

273 single-photon emission computed tomography (SPECT), and invasive coronary angiography.

274 single-photon emission computed tomography (SPECT), with clinical follow-up for >/= 6 months.

275 single-photon emission computed tomography (SPECT).

276 single photon emission computed tomography (SPECT)/computed tomography (CT) (n = 15) studies targeti

277 single photon emission computed tomography (SPECT)/computed tomography (CT), and tissue analysis.

278 single-photon emission computed tomography (SPECT)/computed tomography (CT), autoradiography, and fl

279 single-photon emission computed tomography (SPECT)/CT and multiphasic CT scan, and/or magnetic reson

280 single-photon-emission-computed-tomography (SPECT) in conjunction with (99m)Technecium-labelled reco

281 gle Photon Emission Computerized Tomography (SPECT) images obtained during rest or a saline infusion

282 ging with single-photon emission tomography (SPECT) or positron emission tomography (PET) and coronar

283 Four weeks after transplantation, SPECT/CT images were acquired 1 h after injection of (11

284 t (LNI) underwent pelvic (99m)Tc-trofolastat SPECT/CT before radical prostatectomy with extended pelv

285 (99m)Tc-trofolastat SPECT/CT detected LNI with a sensitivity of 50% and spec

286 Conclusion:(99m)Tc-trofolastat SPECT/CT detects PCa with high sensitivity in patients w

287 ssess the performance of (99m)Tc-trofolastat SPECT/CT in a phase 2 multicenter, multireader prospecti

288 patients with a history of CAD who underwent SPECT between 1991 and 2012 (mean age, 66.2+/-10.9 years

289 determination was found to be an unsmoothed SPECT/CT reconstruction in combination with a recovery c

290 The present study used SPECT/CT to evaluate whether priming of ECFCs with eryth

291 change in regional cerebral blood flow using SPECT with (99m)Tc-labeled hexamethylpropyleneamine oxim

292 ct prostate cancer (PCa) noninvasively using SPECT.

293 N)-facilitated NSC tracking in the brain via SPECT.

294 taining orthotopic breast tumors for in vivo SPECT/MRI and biodistribution studies after injection wi

295 In vivo, SPECT visualizes actively migrating NSCs toward glioma x

296 R), recruitment of immune cells ((111)In-WBC SPECT), or enhanced glycolytic flux seen in inflammatory

297 ients were discharged after imaging, whereas SPECT/CT patients left the department earlier, just afte

298 (18)F-NaF PET/CT or PET/MRI as compared with SPECT/CT and pBS in this patient population with a relat

299 for myocardial perfusion imaging (MPI) with SPECT on the estimated lifetime attributable risk (LAR)

300 ally targets macrophages, could be used with SPECT/CT to image pancreatic inflammation in a relevant